We are live on ! Find out more
WC

Westhampton Capital Portfolio holdings

AUM $241M
1-Year Est. Return 38.64%
This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+38.64%
3 Year Est. Return
+95.59%
5 Year Est. Return
+130.02%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$3.85M
Cap. Flow
-$4.79M
Cap. Flow %
-3.88%
Top 10 Hldgs %
35.23%
Holding
113
New
4
Increased
17
Reduced
51
Closed
3

Top Buys

Rank Stock Value
1
RIO icon
Rio Tinto
RIO
+$442K
2
BMY icon
Bristol-Myers Squibb
BMY
+$438K
3
QQQ icon
Invesco QQQ Trust
QQQ
+$201K
4
HD icon
Home Depot
HD
+$170K
5
TFC icon
Truist Financial
TFC
+$150K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$482K
2
KMI icon
Kinder Morgan
KMI
+$382K
3
AAPL icon
Apple
AAPL
+$374K
4
CLX icon
Clorox
CLX
+$310K
5
PEP icon
PepsiCo
PEP
+$272K

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.86%
2 Industrials 20.95%
3 Technology 11.75%
4 Consumer Discretionary 10.45%
5 Healthcare 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOW icon
76
Dow Inc
DOW
$20.8B
$458K 0.37%
8,361
– –
JPM icon
77
JPMorgan Chase
JPM
$947B
$421K 0.34%
3,022
-500
-14% -$64.1K
QCOM icon
78
Qualcomm
QCOM
$179B
$419K 0.34%
4,750
– –
SWKS icon
79
Skyworks Solutions
SWKS
$9.54B
$415K 0.34%
3,435
– –
HAL icon
80
Halliburton
HAL
$26.8B
$384K 0.31%
15,710
+110
+0.7% +$2.32K
RDS.B
81
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$358K 0.29%
5,970
+40
+0.7% +$2.35K
NVDA icon
82
NVIDIA
NVDA
$4.76T
$353K 0.29%
60,000
-12,000
-17% -$62.4K
WFC icon
83
Wells Fargo
WFC
$264B
$331K 0.27%
6,155
+200
+3% +$10.5K
VMC icon
84
Vulcan Materials
VMC
$36.9B
$323K 0.26%
2,245
-55
-2% -$7.87K
TGT icon
85
Target
TGT
$63.7B
$321K 0.26%
2,500
– –
SPLV icon
86
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$315K 0.26%
5,400
– –
V icon
87
Visa
V
$689B
$302K 0.24%
1,605
+95
+6% +$17.1K
CMA
88
DELISTED
Comerica
CMA
$300K 0.24%
4,175
-2,600
-38% -$178K
GE icon
89
GE Aerospace
GE
$375B
$295K 0.24%
5,303
-1,405
-21% -$72.6K
NSC icon
90
Norfolk Southern
NSC
$77.1B
$291K 0.24%
1,500
– –
REGN icon
91
Regeneron Pharmaceuticals
REGN
$69.9B
$282K 0.23%
750
– –
FLS icon
92
Flowserve
FLS
$9.29B
$279K 0.23%
5,600
-400
-7% -$19.1K
BWA icon
93
BorgWarner
BWA
$13.1B
$278K 0.23%
7,270
– –
ABBV icon
94
AbbVie
ABBV
$454B
$274K 0.22%
3,100
– –
BRK.B icon
95
Berkshire Hathaway Class B
BRK.B
$1.07T
$266K 0.22%
1,175
+20
+2% +$4.34K
TRV icon
96
Travelers Companies
TRV
$81.4B
$265K 0.21%
1,938
-570
-23% -$77.6K
ACN icon
97
Accenture
ACN
$94.3B
$257K 0.21%
1,220
– –
IP icon
98
International Paper
IP
$22.5B
$253K 0.21%
5,797
– –
USB icon
99
US Bancorp
USB
$98.9B
$249K 0.2%
4,206
– –
CTVA icon
100
Corteva
CTVA
$58.6B
$241K 0.2%
8,148
-310
-4% -$8.21K
1 2 3
4
5

Similar funds

PFWA
Paces Ferry Wealth Advisors Atlanta, Georgia $241M AUM 17.16% 1-Year Est. Return
SIM
Sherborne Investors Management New York $241M AUM 35.23% 1-Year Est. Return
AA
Altman Advisors Chicago, Illinois $241M AUM 31.3% 1-Year Est. Return
TTA
Thor Trading Advisors Greensburg, Pennsylvania $241M AUM 16.84% 1-Year Est. Return
RS
Rakuten Securities Tokyo, Japan $241M AUM 94.43% 1-Year Est. Return
DCM
Dean Capital Management Overland Park, Kansas $241M AUM 32.7% 1-Year Est. Return
GL
GHE LLC Memphis, Tennessee $241M AUM 34.93% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $242M AUM 35.05% 1-Year Est. Return

Westhampton Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Westhampton Capital held 113 positions worth $123M, up 3.2% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Westhampton Capital withdrew a net $4.79M in Q4 2019, closing 3 positions and reducing 51 holdings. Its most notable exit was Celgene Corp, an estimated $482K position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Technology.

Against the trend, Westhampton Capital opened a new position in Rio Tinto worth $483K.

  • Westhampton Capital's largest Q4 2019 buy was Rio Tinto: 8,140 shares worth $483K.
  • Westhampton Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $438K increase.
  • Westhampton Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $374K.
  • Westhampton Capital fully exited Celgene Corp in Q4 2019, selling an estimated $482K.
  • Westhampton Capital's ten largest holdings make up 35% of its $123M portfolio in Q4 2019.
  • Westhampton Capital opened 4 new positions and closed 3 in Q4 2019.
  • Westhampton Capital's portfolio value rose 3.2% quarter-over-quarter to $123M.

Based on Westhampton Capital's 13F filing for Q4 2019, filed 30 Jan 2020.